noom glp 1 microdose cost Noom's GLP-1Rx Program: A Cost-Effective Alternative | Nicholas Saraceno posted on the topic Medical support meets weight loss

Lancet Title: Tirzepatide Once Weekly for the Treatment of Obesity in People With Type 2 Diabetes (Surmount-2): A Double-Blind, Randomised, Multicentre, Placebo-Controlled, Phase 3 Trial

ClinicalTrials.gov TRIUMPH-4: A Study of Retatrutide (LY3437943) in Participants With Obesity and Knee Osteoarthritis (NCT05929066)

Aroda VR, Blonde L, Pratley RE

You pay a simple monthly membership that covers all your office visits, consultations, and follow-up monitoring with no copays, no referrals, and no prior authorization delays

Industry researchers estimate that while about 12% of United States citizens have used a GLP-1 medication for weight loss, 54% of adults who have taken GLP-1s say it was difficult to afford, and 53% say it was still too expensive even if they received insurance coverage for the medication